Star Lake BioscienceZhaoqing Guangdong Future Growth

Future criteria checks 1/6

Star Lake BioscienceZhaoqing Guangdong is forecast to grow earnings and revenue by 18.1% and 3.1% per annum respectively. EPS is expected to grow by 18.1% per annum. Return on equity is forecast to be 14.4% in 3 years.

Key information

18.1%

Earnings growth rate

18.1%

EPS growth rate

Food earnings growth	22.3%
Revenue growth rate	3.1%
Future return on equity	14.4%
Analyst coverage	Low
Last updated	30 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600866 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	18,479	1,356	N/A	3,210	2
12/31/2025	17,823	1,197	N/A	1,380	2
12/31/2024	17,062	1,026	N/A	2,416	2
9/30/2024	17,435	866	1,647	2,173	N/A
6/30/2024	17,594	954	1,593	2,009	N/A
3/31/2024	17,410	809	2,150	2,512	N/A
12/31/2023	17,374	678	1,650	2,026	N/A
9/30/2023	17,343	598	1,231	1,503	N/A
6/30/2023	16,932	429	1,345	1,680	N/A
3/31/2023	17,479	546	445	845	N/A
12/31/2022	17,486	608	1,210	1,663	N/A
9/30/2022	16,084	595	1,493	2,009	N/A
6/30/2022	12,294	497	181	630	N/A
3/31/2022	7,938	301	-78	312	N/A
12/31/2021	4,071	152	-182	168	N/A
9/30/2021	1,170	96	-38	171	N/A
6/30/2021	1,129	130	-123	142	N/A
3/31/2021	1,134	151	-114	210	N/A
12/31/2020	1,116	149	-40	250	N/A
9/30/2020	1,011	137	-150	159	N/A
6/30/2020	1,081	156	-104	171	N/A
3/31/2020	1,038	145	2	183	N/A
12/31/2019	1,050	150	56	213	N/A
9/30/2019	1,061	132	136	226	N/A
6/30/2019	969	103	150	181	N/A
3/31/2019	926	71	75	104	N/A
12/31/2018	859	42	17	51	N/A
9/30/2018	849	-82	-23	16	N/A
6/30/2018	852	-101	N/A	28	N/A
3/31/2018	805	-124	N/A	72	N/A
12/31/2017	687	-158	N/A	50	N/A
9/30/2017	668	-35	N/A	52	N/A
6/30/2017	634	1	N/A	34	N/A
3/31/2017	638	22	N/A	28	N/A
12/31/2016	680	24	N/A	41	N/A
9/30/2016	618	-232	N/A	11	N/A
6/30/2016	621	-333	N/A	2	N/A
3/31/2016	656	-397	N/A	-11	N/A
12/31/2015	730	-422	N/A	3	N/A
9/30/2015	882	-312	N/A	60	N/A
6/30/2015	923	-319	N/A	89	N/A
3/31/2015	912	-353	N/A	53	N/A
12/31/2014	871	-361	N/A	-20	N/A
9/30/2014	819	-163	N/A	-57	N/A
6/30/2014	817	-77	N/A	-58	N/A
3/31/2014	856	19	N/A	-81	N/A
12/31/2013	903	20	N/A	-28	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600866's forecast earnings growth (18.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 600866's earnings (18.1% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 600866's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600866's revenue (3.1% per year) is forecast to grow slower than the CN market (14% per year).

High Growth Revenue: 600866's revenue (3.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600866's Return on Equity is forecast to be low in 3 years time (14.4%).

Star Lake BioscienceZhaoqing Guangdong Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.16 in 3Q 2023)

Investor sentiment improves as stock rises 16%

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 18%

Now 20% undervalued

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2024 Results on Aug 27, 2024

New minor risk - Share price stability

Now 23% overvalued after recent price rise

Investor sentiment improves as stock rises 28%

New minor risk - Financial position

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.073 in 1Q 2023)

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Annual General Meeting, May 13, 2024

Investor sentiment improves as stock rises 25%

Now 21% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q1, 2024 Results on Apr 23, 2024

Now 21% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Now 22% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.053 in 3Q 2022)

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CN¥0.066 (vs CN¥0.075 in 2Q 2022)

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2023 Results on Aug 29, 2023

Full year 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.14 in FY 2021)

Less than half of directors are independent

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies